{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:25:34Z","timestamp":1791260734481,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00213-013-3422-0","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T03:58:28Z","timestamp":1389067108000},"page":"2525-2531","source":"Crossref","is-referenced-by-count":32,"title":["Quetiapine extended-release (Seroquel-XR) versus amitriptyline monotherapy for treating patients with fibromyalgia: a 16-week, randomized, flexible-dose, open-label trial"],"prefix":"10.1007","volume":"231","author":[{"given":"Elena P.","family":"Calandre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rico-Villademoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Molina-Barea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan S.","family":"Vilchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen M.","family":"Rodriguez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Hidalgo-Tallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piedad","family":"Morillas-Arques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"key":"3422_CR1","first-page":"771","volume":"104","author":"J Alonso","year":"1995","unstructured":"Alonso J, Prieto L, Ant\u00f3 JM (1995) The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin (Barc) 104:771\u2013776","journal-title":"Med Clin (Barc)"},{"key":"3422_CR2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0025-7753(03)73601-X","volume":"120","author":"X Badia","year":"2003","unstructured":"Badia X, Muriel C, Gracia A et al (2003) Validaci\u00f3n espa\u00f1ola del cuestionario Brief Pain Inventory en pacientes con dolor de causa neopl\u00e1sica. Med Clin (Barc) 120:52\u201359","journal-title":"Med Clin (Barc)"},{"key":"3422_CR3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S1461145709990423","volume":"13","author":"B Bandelow","year":"2010","unstructured":"Bandelow B, Chouinard G, Bobes J et al (2010) Extended-quetiapine fumarate (quetiapine XR): a one-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. Int J Neuropsychopharmacol 13:305\u2013320","journal-title":"Int J Neuropsychopharmacol"},{"key":"3422_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0889-857X(01)00011-4","volume":"28","author":"A Barkhuizen","year":"2002","unstructured":"Barkhuizen A (2002) Rational and targeted pharmacologic treatment of fibromyalgia. Rheum Dis Clin North Am 28:261\u2013290","journal-title":"Rheum Dis Clin North Am"},{"key":"3422_CR5","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2337\/dc12-0656","volume":"35","author":"J Boyle","year":"2012","unstructured":"Boyle J, Eriksson ME, Gribble L et al (2012) Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care 35:2451\u20132458","journal-title":"Diabetes Care"},{"key":"3422_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/11597130-000000000-00000","volume":"6","author":"EP Calandre","year":"2012","unstructured":"Calandre EP, Rico-Villademoros F (2012) The role of antipsychotics in the management of fibromyalgia. CNS Drugs 6:135\u2013153","journal-title":"CNS Drugs"},{"key":"3422_CR7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2474-12-95","volume":"12","author":"EP Calandre","year":"2011","unstructured":"Calandre EP, Morillas-Arques P, Molina-Barea R et al (2011) Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. BMC Musculoskeletal Disord 12:95","journal-title":"BMC Musculoskeletal Disord"},{"key":"3422_CR8","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1345\/aph.1Q697","volume":"46","author":"HV Coe","year":"2012","unstructured":"Coe HV, Hong IS (2012) Safety of low doses of quetiapine when used for insomnia. Ann Pharmacother 46:718\u201322","journal-title":"Ann Pharmacother"},{"key":"3422_CR9","first-page":"421","volume":"174","author":"S Cohrs","year":"2004","unstructured":"Cohrs S, Rodenbeck A, Guan Z et al (2004) Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacol (Berl) 174:421\u2013429","journal-title":"Psychopharmacol (Berl)"},{"key":"3422_CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1699-258X(07)73594-5","volume":"3","author":"J Esteve-Vives","year":"2007","unstructured":"Esteve-Vives J, Rivera Redondo J, Salvat Salvat MI et al (2007) Propuesta de una versi\u00f3n de consenso del Fibromyalgia Impact Questionnaire (FIQ) para la poblaci\u00f3n espa\u00f1ola. Reumatol Clin 3:21\u201324","journal-title":"Reumatol Clin"},{"key":"3422_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/FTD.0b013e3182603f62","volume":"34","author":"DS Fisher","year":"2012","unstructured":"Fisher DS, Handley SA, Flanagan RJ et al (2012) Plasma concentrations of quetiapine, N-desalkylquetiapine, o-desalkylquetiapine, 7-hydroxyquetiapine, and quetiapine sulfoxide in relation to quetiapine dose, formulation and other factors. Ther Drug Monit 34:415\u2013421","journal-title":"Ther Drug Monit"},{"key":"3422_CR12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4088\/JCP.09r05535gre","volume":"72","author":"K Gao","year":"2011","unstructured":"Gao K, Kemp DE, Fein E et al (2011) Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics. J Clin Psychiatry 72:1063\u20131071","journal-title":"J Clin Psychiatry"},{"key":"3422_CR13","volume-title":"ECDEU assessment manual for psychopharmacology\u2014revised (DHEW Publ No ADM 76-338)","author":"W Guy","year":"1976","unstructured":"Guy W (1976) ECDEU assessment manual for psychopharmacology\u2014revised (DHEW Publ No ADM 76-338). U.S. Department of Health, Rockville"},{"key":"3422_CR14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpain.2010.01.002","volume":"11","author":"W H\u00e4user","year":"2010","unstructured":"H\u00e4user W, Petzke F, Sommer C (2010) Comparative efficacy and harms of duloxetine, milnacipran and pregabalin in fibromyalgia syndrome. J Pain 11:505\u2013521","journal-title":"J Pain"},{"key":"3422_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/11598970-000000000-00000","volume":"26","author":"W H\u00e4user","year":"2012","unstructured":"H\u00e4user W, Wolfe F, T\u00f6lle T et al (2012) The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs 26:297\u2013307","journal-title":"CNS Drugs"},{"key":"3422_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2006.06.023","volume":"31","author":"J Hidalgo","year":"2007","unstructured":"Hidalgo J, Rico-Villademoros F, Calandre EP (2007) An open-label study of quetiapine in the treatment of fibromyalgia. Prog Neuropsychopharmacol Biol Psychiatry 31:71\u201377","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3422_CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/YIC.0b013e32833e34d9","volume":"26","author":"MA Katzman","year":"2011","unstructured":"Katzman MA, Brawman-Mintzer O, Reyes EB et al (2011) Extended-release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial. Int Clin Psychopharmacol 26:11\u201324","journal-title":"Int Clin Psychopharmacol"},{"key":"3422_CR18","first-page":"47","volume":"3","author":"KF Marshall Le","year":"2011","unstructured":"Le Marshall KF, Littlejohn GO (2011) Management strategies for fibromyalgia. Open Access Rheumatol Res Rev 3:47\u201351","journal-title":"Open Access Rheumatol Res Rev"},{"key":"3422_CR19","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1517\/14656566.8.9.1211","volume":"8","author":"RS McIntyre","year":"2007","unstructured":"McIntyre RS, Soczynska JK, Woldeyoannes HO et al (2007) A preclinical and clinical rationale for quetiapine in mood syndromes. Expert Opin Pharmacother 8:1211\u20131219","journal-title":"Expert Opin Pharmacother"},{"key":"3422_CR20","author":"A McIntyre","year":"2013","unstructured":"McIntyre A, Paisley D, Kuoassi E, Gendron A (2013) Quetiapine fumarate extended release or the treatment of major depression with comorbid fibromyalgia syndrome a double-blind, randomized, placebo controlled study. Arthritis Rheum. doi: 10.1002\/art38228","journal-title":"Arthritis Rheum"},{"key":"3422_CR21","unstructured":"Moore N, McMillan P, Birur B, et al. (2011) Fibromyalgia: efficacy of quetiapine compared with placebo [Abstract no. NR08\u201348:333]. In 164th annual meeting of the American Psychiatric Association. Honolulu, Hawaii"},{"key":"3422_CR22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/JCP.0b013e318267b8ca","volume":"2","author":"S Potvin","year":"2012","unstructured":"Potvin S, Morin M, Cloutier C et al (2012) Add-on treatment of quetiapine for fibromyalgia. A pilot, randomized, double-blind, placebo-controlled 12-week trial. J Clin Psychopharmacol 2:684\u2013687","journal-title":"J Clin Psychopharmacol"},{"key":"3422_CR23","first-page":"81","volume":"9","author":"A Royuela","year":"1997","unstructured":"Royuela A, Mac\u00edas JA (1997) Propiedades clinim\u00e9tricas de la versi\u00f3n castellana del cuestionario de Pittsburgh. Vigilia-Sue\u00f1o 9:81\u201394","journal-title":"Vigilia-Sue\u00f1o"},{"key":"3422_CR24","first-page":"282","volume":"15","author":"M Shemo","year":"2003","unstructured":"Shemo M, Shemo JPD, Anderson M (2003) Beneficial effects of quetiapine treatment in patients with fibromyalgia [Abstract]. J Neuropsychiatry Clin Neurosci 15:282","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"3422_CR25","volume-title":"STAI Cuestionario de Ansiedad Estado-Rasgo. Manual (6\u00aa edici\u00f3n). Publicaciones de Psicolog\u00eda Aplicada. Serie menor n\u00famero 124","author":"CD Spielberger","year":"2002","unstructured":"Spielberger CD, Gorsuch RL, Lushene RE (2002) STAI Cuestionario de Ansiedad Estado-Rasgo. Manual (6\u00aa edici\u00f3n). Publicaciones de Psicolog\u00eda Aplicada. Serie menor n\u00famero 124. TEA Ediciones S.A, Madrid"},{"key":"3422_CR26","first-page":"403","volume":"8","author":"C Vazquez","year":"1997","unstructured":"Vazquez C, Sanz J (1997) Fiabilidad y valores normales de la versi\u00f3n espa\u00f1ola del inventario para la depresi\u00f3n de Beck de 1978. Clin Salud 8:403\u2013422","journal-title":"Clin Salud"},{"key":"3422_CR27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S146114571000101X","volume":"14","author":"Z Wang","year":"2011","unstructured":"Wang Z, Kemp DE, Chan PK et al (2011) Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder. Int J Neuropsychopharmacol 14:131\u2013142","journal-title":"Int J Neuropsychopharmacol"},{"key":"3422_CR28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33:160\u2013172","journal-title":"Arthritis Rheum"},{"key":"3422_CR29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/da.21952","volume":"29","author":"CH Wu","year":"2012","unstructured":"Wu CH, Farley JF, Gaynes BN (2012) The association between antidepressant dosage titration and medication adherence among patients with depression. Depress Anxiety 29:506\u2013514","journal-title":"Depress Anxiety"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3422-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3422-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3422-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:40:34Z","timestamp":1647888034000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3422-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["3422"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3422-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,8]]}}}